What's Happening?
Lokahi Longevity, a Honolulu-based clinic, is promoting a blood test that measures high-sensitivity C-reactive protein (hs-CRP) to assess inflammation's impact on aging, termed 'inflammaging.' The clinic, co-founded by David Watumull, aims to make this
test widely available in Hawaiʻi. According to the American College of Cardiology, hs-CRP is a strong predictor of cardiovascular risk. Lokahi Longevity's initiative is based on findings that reducing hs-CRP and cholesterol levels can lower the risk of major adverse cardiovascular events by 44%. The clinic hopes to raise awareness about the health impacts of inflammation and its role in aging.
Why It's Important?
The introduction of hs-CRP testing in Hawaiʻi is crucial as it addresses the growing recognition of inflammation as a significant factor in aging and cardiovascular health. By making this test more accessible, Lokahi Longevity aims to enhance preventive healthcare measures and reduce the incidence of heart disease. This initiative could lead to better management of cardiovascular risks and improve overall health outcomes. The focus on 'inflammaging' reflects a broader trend in healthcare to address the underlying causes of aging-related diseases, potentially leading to more effective interventions and healthier aging populations.
What's Next?
As Lokahi Longevity continues to promote hs-CRP testing, it may influence healthcare practices and encourage other clinics to adopt similar preventive measures. The increased availability of this test could lead to more widespread screening and early detection of cardiovascular risks. Additionally, the clinic's efforts may prompt further research into the role of inflammation in aging and inspire new strategies for managing age-related health issues. The success of this initiative could also drive policy changes to support preventive healthcare and improve access to diagnostic tools.
